MOLECULAR CELLULAR BIOLOGY, Feb. 1991, p. 620-631                                                                   Vol. 11,  2
0270-7306/91/020620-12$02.00/0
Copyright © 1991, American Society Microbiology


   Cloning Characterization ERG8, Essential Gene Saccharomyces cerevisiae Encodes Phosphomevalonate Kinase
                                   YIM H. TSAY GORDON W. ROBINSON*
 Department Cellular Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543
                                            Received 8 August 1990/Accepted 30 October 1990

             Saccharomyces cerevisiae strains contain erg8-1 mutation temperature sensitive growth            defect phosphomevalonate kinase, enzyme isoprene ergosterol biosynthesis. plasmid bearing
           yeast ERG8 gene isolated YCp5O genomic library functional complementation erg8-1
           mutant strain. Genetic analysis demonstrated integrated copies ERG8 plasmid mapped erg8
           locus, confirming identity clone. Southern analysis showed ERG8 single-copy gene.
           Subcloning DNA sequencing defined functional ERG8 regulon 850-bp upstream region            adjacent 1,272-bp open reading frame. deduced 424-amino-acid ERG8 protein showed homology            known proteins putative ATP-binding domain present kinases. Disruption            chromosomal ERG8 coding region integration URA3 HIS3 marker fragments lethal haploid
           cells, indicating gene essential. Expression ERG8 gene S. cerevisiae galactose-
           inducible galactokinase (GALI) promoter resulted 1,000-fold-elevated levels phosphomevalonate kinase
           enzyme activity. Overproduction soluble protein predicted 48-kDa size phosphomevalonate
           kinase observed yeast cells.

  Phosphomevalonate kinase [ATP:(R)-5-phosphomeval-                     erg8 strains cosegregated, suggesting traits onate phosphotransferase; EC 2.7.4.2] catalyzes pyro-               result single genetic defect. erg8 strains phosphorylation mevalonate second steps              recently used explore regulation ergosterol metab-
leading formation isopentenyl diphosphate: (3R)-              olism S. cerevisiae (16, 47), detailed characteriza-
phosphomevalonate        +    ATP   --
                                         (3R)-pyrophosphomeval-         tion yeast gene phosphomevalonate kinase onate + ADP. identified cytoplasmic                 reported.
enzyme    Saccharomyces cerevisiae, phosphomevalonate                   mammalian cells, synthesis sterols isoprenoid
kinase isolated variety plant animal             compounds regulated primarily control key
sources (10, 24, 33, 50). enzyme functions                  enzymes mevalonate formation, HMG coenzyme (CoA)
elaboration isoprene subunits, used                synthase HMG CoA reductase (15). analogous yeast
synthesis variety essential compounds including                 biosynthetic pathway regulated steps
sterols, dolichols, ubiquinones. Isoprene-derived mole-             (12, 47, 53). evidence suggests yeast cules used species covalent modifi-            mammalian cells, significant pathway regulation cation tRNAs (17) specific proteins, including ras           mediated additional enzymes sterol biosynthesis, factor S. cerevisiae (1, 27, 46). Phosphomevalonate                including mevalonate kinase squalene synthetase (18,
kinase pig liver purified homogeneity              20, 52). investigate potential secondary
shown monomeric protein molecular mass                control points pathway, initiated molecular
22 kDa (6, 32). exhibits strong nucleotide specificity           analysis S. cerevisiae enzymes early
ATP utilizes Mg2` preferred cofactor. Chemical                 sterol biosynthesis. report cloning modification studies suggested enzyme                 yeast ERG8 gene phosphomevalonate kinase using
quires cysteine lysine residues activity (7,          erg8-1 mutant complementation approach char-
54), little known structure enzyme           acterization gene DNA sequencing active site.                                                        analyses. ERG8 single-copy essential
   large number temperature-conditional S. cerevisiae              yeast gene encodes protein twice size mutants defective ergosterol biosynthesis isolated           previously reported mammalian enzyme.
Karst et. al (29, 48). erg mutants required ergosterol
supplementation growth 25°C inviable 36°C supplementation. Mutant strains designated erg8-                            MATERIALS METHODS
1, -2, -3 defective phosphomevalo-                 Materials. D-Sorbitol, P-glucuronidase, D-galactose,
nate kinase labeling experiments (29). cells failed            Tween 80, polyethylene glycol 4000 obtained synthesize ergosterol acetate, extracts erg8
cells unable convert mevalonate mevalonate-                  Sigma Chemical  Glass milk (GeneClean) pyrophosphate vitro. Genetic analysis showed erg8               BiolOl, LaJolla, Calif., BioTrans membranes mutations recessive wild-type ERG8 allele                ICN Biomedicals, , Irvine, Calif. Sequenase (modified
heterozygous diploids. addition, experiments dem-              T7 DNA polymerase) U.S. Biochemical Corp.,
onstrated thermosensitive biochemical defects              Cleveland, Ohio.  32P]dCTP,  35S]dATP, 14C-
                                                                        labeled sterol precursors Amersham Corp. 5-Flu-
                                                                        oroorotic acid PCR, , Gainsville, Fla.,                                                                         silica gel LK6D layer chromatography plates   *
      Corresponding author.                                             Whatman. 5-Bromo-4-chloro-3-indolyl-,-D-galactopyrano-
                                                                  620
 VOL. 11, 1991                                     CLONING S. CEREVISIAE PHOSPHOMEVALONATE KINASE                             621

                                                TABLE 1. S. cerevisiae strains
  Strain                                               Genotype                                                        Source
SPi                       MATa erg8-1                                                                              F. Karst
AG8-6B                    MATa erg8-1 his3-11,15 leu2-3,112 trpl-l                                                 study
AG8-2A                    MATa erg8-1 his3-11,15 ura3-1 leu2-3,112 ade2-1                                          study
ET7-6B                    MATa erg8-1 upcl his3-11,15 leu2-3,112 ural                                              study
ET15-6D                   MATa erg8-1 upcl his3-11,15 leu2-3,112 trpl-l ura3                                       study
ET20-2A                   MATa erg8-1 ura3-52 lys2-801                                                             study
W303-1A                   MATa ERG8 ura3-1 his3-11,15 leu2-3,112 trpl-l ade2-1 can1-100                            R. Rothstein
W303-1B                   MATa ERG8 ura3-1 his3-11,15 leu2-3,112 trpl-l ade2-1 canl-100                            R. Rothstein
JT35-1A                   MATa ERG8 upcl ura3-1 his3-11,15 trpl-J ade2-1                                           J. Tkacz
JT35-6B                   MATa ERG8 upcl ural his3 leu2-3,112 trpl-J                                               J. Tkacz
JT42-5B                   MATa ERG8 ura3-1 LYS2                                                                    J. Tkacz
Y294                      MATa ERG8 his3d ura3-52 leu2-3,112 trpl-J GAL                                            M. Haffey
YM197                     MATa/MATa ERG81ERG8 ura3-521ura3-52 Iys2-801/lys2-801 ade2-101/ade2                      J. Rine
ET16                      MATa/MATa ERG81erg8-1 ura3-l/ura3-1 his3-J1,lS/his3-11,15 ade2-llade2-1                  study
                            leu2-3,1121leu2-3,112 TRPl/trpl-l


 Bethesda Research Labs, , Gaithersburg,        yeast transformants rapid glass bead disruption Md. Reagents spectrophotometric assay phos-           phenol extraction (39). Yeast chromosomal DNA pre-
phomevalonate kinase obtained Boehringer           pared method Struhl et al. (51). Large-scale
Mannheim Biochemicals, Indianapolis, Ind., R,S-       preparations minipreparations plasmid DNA 5-phosphomevalonate, kindly provided L.             prepared E. coli boiling method (26). Large
Parker, Bristol-Myers Squibb Pharmaceutical Research          preparations purified centrifugation ce-
stitute, Princeton, N.J.                                         sium chloride-ethidium bromide gradients.
   Strains genomic libraries. S. cerevisiae strains         DNA manipulations. Restriction enzymes DNA
used study described Table 1         modification enzymes purchased Bethesda 
derivatives strain S288C. Escherichia coli strains        search Labs, , New England BioLabs, , used cloning plasmid propagation RR1 [F- pro        used according specifications manufacturers.
leu thi lacY Strf hsdR (rK- MK-) hsdM endol], DH5a [F-           DNA restriction fragments cloning purified supE44 thi-J recAl gyrA96 relAl hsdR17 (rK- MK+) endAl           agarose gels glass milk-sodium iodide procedure (55).
j80dlacZAM15 lacZYA-argF)U169, JM101 [supE thi             Radiolabeled ERG8 probes Southern analysis pre-
recA+ rK+ (lac-proA,B)/F' traD36 proA,B+ laclqZAM15].          pared random oligomer priming (19) purified restriction libraries genomic DNA used work          fragments nick translation kit Boehringer Mann- Nasmyth Tatchell library (38), containing yeast          heim. Unincorporated [32P]dCTP removed DNA inserts high-copy-number vector YEp13 (ob-            labeled probe spin columns (Boehringer Mannheim).
tained ATCC), Siede Eckardt-Schupp             Plasmid constructions. Plasmids used localization library (49), containing yeast DNA inserts low-copy-      ERG8 gene constructed pET45 insertion number vector YCp50 (provided W. Siede).                      restriction fragments  Fig. 3) compatible sites    Genetic methods media. Yeast cells grown 28°C unless indicated. Standard procedures        tetracycline resistance region YCp5O. Overhanging 5' used mating, sporulation, tetrad analysis (37). Auxo-    3' ends restriction fragments converted trophic markers introduced erg8-1 mutant           blunt ends using respective polymerase 3'-exonu-
strain (SP1) cross strain W303-1A. Yeast complete      clease functions T4 DNA polymerase. Plasmid pET58
medium (YC) yeast minimal medium (YM)                contained SalI-BamHI fragment pET53  Fig.
previously described (40). YM supplemented nu-          3), cloned multicopy vector
trients appropriate selective growth strains. YME      YEp352. Plasmid pET48 cloning 4.5-kb
medium prepared supplementation YM 20 ,ug         BamHI fragment pET45 pBR322. 2.1-kb XhoI- ergosterol ml fresh ergosterol stock solution      BamHI fragment derived pET48 used ERG8
prepared Tween 80-ethanol (1:1, vol/vol); YCE medium          probe Southern analysis. YC comparably supplemented. indicated, 2                  Plasmids pET61 pET62, used production galactose substituted 2  glucose carbon           respective URA+  disruptions chromosomal
source YM. Growth S. cerevisiae induction       ERG8 gene, constructed pET48 replacement
GAL) promoter described previously (57). E. coli          1.0-kb XhoI-EcoRV internal fragment ERG8 gene
strains grown 37°C LB medium (35) supple-             appropriate prototrophic marker fragments  Fig.
mented 50 ,ug ampicillin ml select plasmid    6A). Plasmid pET61 constructed piece ligation
transformants.                                                   2.0-kb SphI-SmaI URA3 fragment Ylp5 (51),   Transformations. yeast strains transformed         3.7-kb SphI-PstI fragment pET48 contained spheroplast method (25). erg8 erg8 upcl mutant           ERG8 5' end, 4.2-kb PstI-EcoRV fragment strains grown overnight YCE 25°C sphero-       pET48 contained ERG8 3' end. Plasmid pET62 plasting, transformants harvested YME          constructed analogous piece ligation 2.1-kb
regeneration agar 6 days incubation 25°C. E. coli    SphI-EcoRV HIS3 fragment YEp6 (13) strains transformed CaCl2 method (41).               pET48 fragments described  Linear, disrupted ERG8
  Preparation DNA. Crude plasmid DNA prepared             fragments transformation diploid yeast cells  622    TSAY ROBINSON                                                                                     MOL. CELL. BIOL.

obtained plasmids pET61 pET62 digestion        counted determine extent 14C incorporation PvuII XbaIL                                                 organic solvent-soluble products. layer chromatogra-
   Plasmid pET77, used overproduction phospho-       phy used examine various products vitro
mevalonate kinase, constructed insertion 2.4-kb     reactions. incubation S4K fractions 14C-
XhoI-SalI ERG8 fragment pET48 SalI site        labeled substrates described  aqueous reaction mix-
pMH101 (21). ERG8 coding region properly ori-           tures fractionated silica gel LK6D layer chro-
ented respect GAL) promoter plasmid     matography plates n-propanol-NH40H-water (6:3:1,
Fig. 7A).                                                       vol/vol/vol) solvent  dried plates    DNA sequence analysis. BgIII-XbaI fragment          examined autoradiography.
pET45 sequenced dideoxy-chain termination              Overexpression phosphomevalonate kinase esti-
method Sanger et al. (45)  Fig. 3B). DNA restriction     mated using enzyme assays. sensitive fragments subcloned M13mpl8 M13mpl9                vitro complementation assay, utilized [14C]
primed chain extension 17-bp universal primer,     phosphomevalonate measured conversion [35S]dATP incorporated Sequenase recom-         substrate squalene described  Small amounts
mended manufacturer. Sequences compiled         (ranging 0.001 0.01 ml) S4K fraction putative
analyzed Intelligenetics software programs.        overproducing cells added reaction mixtures EMBL/GenBank PIR data bases searched               contained large (0.15 ml) S4K fraction erg8
homologies DNA protein sequences phospho-         mutant cells. Reactions terminated various times,
mevalonate kinase 5' open reading frame (ORF)           conversion rates determined; S4K fraction peptide.                                                        untransformed wild-type (ERG8) yeast strain used    Southern analysis. Southern blot hybridization analysis      calibrate assay plasmid-transformed strains. spec- performed yeast chromosomal DNA described             trophotometric assay phosphomevalonate kinase previously (40). Genomic DNA digested completion         used measure enzyme overproduction cells bearing EcoRI, restriction fragments separated       pET77 pMH101 plasmids. Conditions assay 0.8  agarose gel. gel blotted BioTrans mem-        previously described (42), 9 mM R,S-phosphome-
brane, hybridized 32P-labeled ERG8 probe       valonate used substrate. generation ADP autoradiographed.                                           ATP phosphomevalonate kinase reaction    Preparation crude extracts. Enzyme extracts pre-     coupled reactions catalyzed pyruvate kinase pared late-logarithmic-phase yeast cells centrifuga-    lactate dehydrogenase, reaction rate monitored
tion suspension cells pellet weight (gram)        340 nm double-beam spectrophotometer.
equivalent 4°C breakage buffer (100 mM Tris hydrochlo-          Determination crude ergosterol content. Nonsaponifiable
ride [pH 7.5]-10 mM P-mercaptoethanol). pellet weight       lipids prepared, crude ergosterol content equivalents acid-washed glass beads (diameter, 0.45 ,um)     yeast cells determined method Karst et. al (47). added, cells disrupted vigorous mixing        Gel electrophoresis yeast proteins. Cultures yeast Vortex Genie  45-s pulses). disrupted cell       strain Y294 contained ERG8 overexpression plasmid
suspension centrifuged 2,400 x g 10 min,       pET77 control plasmid pMH101 (21) grown supernatant removed centrifuged 4,000      YM-glucose YM-galactose 18 h. Cells  x g 15 min. 4,000 x g supernatant (S4K) fraction   harvested, S100K fractions prepared described
used directly 14C-labeled substrate conversion assay      Aliquots contained 20 jig protein mixed centrifuged 100,000 x g 60 min obtain        Laemmli sample buffer (30), boiled 3 min, electro-
soluble S100K fraction, used spectrophoto-     phoresed 12  sodium dodecyl sulfate-polyacrylamide
metric assay phosphomevalonate kinase. Protein concen-      gels (Integrated Separation Systems) described Laem-
trations S4K Sl10K fractions determined      mli (30), stained Coomassie blue stain. Band
method Bradford (14). Enzyme extracts frozen        intensities stained gels quantified densitometric
stored -70°C assay negligible losses          scanning.
phosphomevalonate kinase activity.
   Enzyme assays phosphomevalonate kinase. Comple-                                    RESULTS
mentation erg8 mutant strain assessed biochemi-
cally measuring ability S4K fractions convert         Biochemical genetic analyses erg8-1 mutants.  [14Ciphosphomevalonate sterol precursors, predomi-        temperature-sensitive haploid strains, AG8-2A AG8-6B
nantly squalene. assay functions uncomple-         (Table 1), derived Karst erg8-1 mutant strain SP1
mented erg8 mutants contain enzymes necessary        characterized biochemically attempts clone conversion, phosphomevalonate kinase.        ERG8 gene initiated. Cell extracts prepared action mixtures contained following total volume    erg8 strains possessed detectable phosphomeval-
0.2 ml: 5 mM MgCl2, 4 mM ATP, 1 mM NADPH, 10 mM                 onate kinase activity unable convert ["'C]
 KF, 100 mM Tris hydrochloride (pH 7.5), 0.1 ,uCi [5-14C]    phosphomevalonate, substrate phosphomevalonate ki-
R-phosphomevalonate (58 mCi/mmol), 0.15 ml           nase, product sterol pathway (Fig. 1 S4K fraction. experiments, equivalent amounts        2). contrast, extracts ERG8 wild-type yeast strains
 [2-14C]R-mevalonate (57 mCi/mmol), [14Cipyrophosphome-         capable efficient vitro conversion substrate
valonate (58 mCi/mmol), [1-14C]isopentenyl disphosphate      products, chiefly squalene (Fig. 1), showing  (56 mCi/mmol) substituted labeled phosphomeval-       contained sterol enzymes necessary onate mixture. Reactions incubated 37°C      conversion. ERG8 erg8 extracts equally capable  20 min terminated addition 0.8 ml CHCl3-      converting ["'C]pyrophosphomevalonate, product phos-
 methanol (2:1, vol/vol). phases vortexed briefly      phomevalonate kinase, squalene. Similar experiments
 separated low-speed centrifugation. organic         ["'C]mevalonate (Fig. 1) ["'C]isopentenyl diphos-
 phase removed, washed twice methanol,             phate (data shown) substrates confirmed  VOL . 1 l, 1991




    MEV.




   
      




enzyme
               erg




squalene synthesis.




        4)
                     +

                                           1 2




                      *




                     12
                           + +

                           B


                          erg8

                      YC:p5O
                              +}
                                    3 4 5 6 7 8 9
                                   00 V




                                   C                                      I1




                                   MEV-5-P
                                     (B)
                                          +



                                          .--




  FIG. 1. Complementation biochemical
                                                  B
                                                   +




                                                  erg8
                                                   +

                                                  pET45
                                                       +

                                                       C




                                                       erg




mutant strain. Cell extracts prepared ERG8 (wild-type)
yeast strain YCp5O- pET45-transfo rmed erg8-1 mutant
strain incubated indicated '4C-labe led sterol precursor
  B, C) 20 min 37°C. Equal amoun total reaction
mixture applied layer chromatogr; developed described Materials M
tion standard compounds   B, C, E )) plates indicated arrows. Abbreviations: MEV., mev; alonate; MEV.-5-P,
phosphomevalonate; MEV.-5-PP, pyrophosphormevalonate.



          defect erg8 strains tstricted phos-
phomevalonate kinase affected later steps   Initial attempts transform erg8 str ains showed                                                              XI




                                                             8
                                                                  #




                                                                   +

                                                                  B C
                                                                       +




                                                                    ERG8
                                                                           +



                                                                           ._




                                                                       MEV-5-PP-
                                                                          (C)
                                                                                      ~
                                                                                 -Squaalene

                                                                                '-MEMf.  




                                                                                 MEV. -5-P

                                                                                -MEV.1-5-PP
                                                                                              (D)




                                                                                              (B)
                                                                                               (C)
                                                                                                    CLONING S. CEREVISIAE PHOSPHOMEVALONATE KINASE




                                                                                                    Squaene
                                                                                                      (D)
                                                                                       defect erg8-1



                                                                                      aepthydslatehse mich
                                                                                                              growth YCE poor recipients                                                                                                               plasmid DNA, yielding 1 2 transformants ,ug                                                                                                               DNA. Plating erg8 strains YME medium                                                                                                               temperatures 25°C reduced colony-forming abil-
                                                                                                              ity, expected, additionally produced colony size
                                                                                                              heterogeneity complicate screening yeast
                                                                                                              libraries plasmids capable reversing erg8 temper-
                                                                                                              ature-sensitive phenotype. appeared likely                                                                                                               strain characteristics function                                                                                                               impaired synthesis ergosterol inefficient uptake                                                                                                               ergosterol, upcl mutation (34), known                                                                                                               enhance uptake ergosterol aerobically grown yeast
                                                                                                              cells, crossed erg8 strains. resulting erg8
                                                                                                              upcl strains, ET7-6B ET15-6D (Table 1), grew
                                                                                                              better YME 25°C parent erg8 strains                                                                                                               formed colonies uniform size temperatures.
                                                                                                              Like parent strains, erg8 upcl strains formed fewer
                                                                                                              colonies YME elevated temperatures 34°C.
                                                                                                              erg8 upcl strains better recipients                                                                                                               plasmid DNA erg8 strains, giving 20 50 transfor-
                                                                                                              mants ,ug DNA.
                                                                                                                 Cloning ERG8 gene functional complementation.
                                                                                                              Yeast recombinant DNA libraries screened isolate
                                                                                                              candidate ERG8 plasmid clones. erg8 strain ET7-6B                                                                                                               transformed leucine prototrophy high-copy-
                                                                                                              number Nasmyth Tatchell library (38), strain
                                                                                                              ET15-6D transformed uracil prototrophy                                                                                                               low-copy-number Siede Eckhardt-Schupp library (49).
                                                                                                              Approximately 35,000 LEU+ transformants                                                                                                               Nasmyth Tatchell library equal number URA+
                                                                                                              transformants Siede Eckhardt-Schupp library
                                                                                                              separately pooled screening.
                                                                                                                 Transformant pools screened ERG8 gene                                                                                                               spreading cells YME selecting cells capable                                                                                                               colony formation 2 days 34°C. LEU+
                                                                                                              transformant pool, 2 5 cells formed colonies                                                                                                               10,000 cells plated. Extracts prepared colonies
                                                                                                              assayed biochemically ability convert
                                                                                                              ['4C]mevalonate organic solvent-soluble products (Ma-
                                                                                                              terials Methods). LEU+ candidate cells                                                                                                               efficient conversion untransformed erg8
                                                                                                              upcl cells, colonies characterized.
                                                                                                              URA+ transformant pool, 5 10 cells formed
                                                                                                              colonies 34°C 10,000 cells plated. Cell extracts
                                                                                                              URA+ candidates tested biochemically,                                                                                                               ability convert [14C]mevalonate squalene.
                                                                                                                                                                         623




                                                                                                              efficient wild-type cells
                                                                                                                 Plasmid DNA extracted 22 ERG8 candidate colonies
   er
    C
            41)
         >                                                                                                    amplified E. coli examined restriction enzyme
      OC
     0>
    Xxo
       c
                                                                                                              analysis. unrelated plasmids identified. Cells        (,)                                                                                                    carried plasmids partially complemented
   
                                                                                                              erg8 biochemical defect analyzed
                                                                                                               Cells carried plasmid completely
                                                                                                              complemented. plasmid, designated pET45, 
                                                                                       ,________
                                                                                               ^              tained 4.5-kb insert restriction sites shown Fig.
                          2                   5                      10                15      20             3A. verify contained ERG8 gene, pET45                                                                   rime (min.)                                 transformed erg8 strain lacked upcl mutation
  FIG. 2. Effect ERG8 plasmid copy number phosphomeval-                                                 strain ET15-6D. pET45 transformants strain
onate kinase activity. Equivalent, small amounts  cell extract                                        AG8-2A viable YM 37°C, extracts untransformed ERG8 strain (-) fr(Dm ERG8 strain                                               cells showed '4C-labeled substrate conversion ability
transformed multicopy ERG8 plasmi4 d pET49 (0) mixed excess erg8-1 mutant extract measure enzymatic                                            characteristic wild-type cells (Fig. 1). test complementation. Mixed extracts incubati ed 14C-labeled                                             premise pET45 contained ERG8 structural gene, phosphomevalonate various times 37°C, md conversion                                             entire 4.5-kb insert subcloned YEp24 generate
products measured described Mateirials Methods.                                                 high-copy-number plasmid pET49. plasmid Unsupplemented erg8-1 mutant extracts   verted <2,000 cpm                                               transformed wild-type strain W303-1A, extracts products times incubation.                                                                     prepared pET49 transformants untrans-
 624     TSAY ROBINSON                                                                                                               MOL. CELL. BIOL.

                    
                          PLASMID                                                                                      ERG 8 FUNCTION
                                      B R          LA   Pa   Bg            BgXS   Aa SsHXbE              Xb   R Ba
                           pET45    S~ ~ ~               -               _____
                                                                               aIII                                                                                                                     '
                             I1
                             pET                                                                                                                                                                                        0 .SKb'
                           pET 51
                           pET 53
                           pET 74                                                                                            +
                           pET 52
                           pET 63                                                                                            +
                           pET 54
                           pET 64
                     B.                                                           -----1   ---   -----




                                                                  W-   ~    -0-             .-~
                                                                                            ~




   FIG. 3. Restriction map pET45 various deletion plasmids sequencing strategy ERG8 gene.   Location restriction
sites 4.5-kb insert pET45. arrow indicates location direction transcription ERG8 gene. location incomplete ORF indicated bracket. phenotypic biochemical complementation ability (ERG8+) various YCp5O-based
deletion plasmids extent ERG8 region DNA present shown. (B) Diagrammatic representation strategy used sequencing ERG8 gene flanking regions pET45. Restriction enzyme sites:  AccI; B, BamHI; Bg, BglII; E, EcoRV; H, HindIII;
L, Sall; P, PvuI; S, SphI; Ss, SspI; R, EcoRI; X, XhoI; Xb, XbaI.

formed cells. shown earlier, erg8 extracts contain                      end ERG8 gene situated enzymes squalene synthesis phosphomeval-                            BglII sites pET45. pET52 failed complement,
onate kinase, possible complement                        odds finding pET63 fully comple-
deficiency vitro addition small quantities                        mented erg8 mutant pET63 contained extract ERG8 cells. Using approach, relative                        smaller pET45 fragment. possible explanation phosphomevalonate kinase extracts esti-                          anomaly provided nucleotide sequence mated measuring increased rate [14C]phosphome-                          ERG8 gene discussed  Plasmids pET54 valonate conversion (Fig. 2). mixing assays,                         pET64, terminated XbaI EcoRV sites, respec- determined pET49 resulted approximately                            tively, failed complement erg8 mutation, indicating
eightfold overproduction phosphomevalonate kinase.                             end ERG8 gene situated 
Analogous experiments described sterol                        stream EcoRV site pET45.
biosynthetic genes S. cerevisiae similar gene-dosage                          Nucleotide predicted ERG8 polypeptide sequences. effects reported (2, 43).                                               strategy used determination ERG8 DNA
   Genetic verification ERG8 clone. establish                       sequence shown Fig. 3B, complete nucleotide
identity putative ERG8 clone, ability pET45                         sequence shown Fig. 4. 2,399-bp region sequenced
DNA target integration plasmid homologous                             spanned distal BglII XbaI sites pET45 (Fig.
recombination yeast erg8 locus examined.                           3A) included 846 bp 5'-flanking sequences 278 bp purpose, SalI-BamHI fragment pET45 sub-                             3'-flanking sequences. presumptive ERG8 coding
cloned YIp5 (Materials Methods), vector                           region starts 3 bp XhoI site continues 1,272
contains yeast URA3 gene lacks yeast replication                        bp, terminating TAA codon. ERG8 ORF capable
origin (51). resultant plasmid, pET46, cut                         encoding 424-amino-acid polypeptide predicted
ERG8 sequences unique SphI site transformed                         molecular weight 47,328. TACTAAC-like intron  erg8 strain ET20-2A. Stable URA+ transformants se-
lected 25°C grew 37°C biochemically
ERG8. URA+ integrant crossed wild-                                 TABLE 2. Genetic analysis ERG8 plasmid integrantsa
type strain JT42-5B diploids, sporulated subjected tetrad analysis. tetrads exam-                          Segregation ERG                   Segregation L YS ined, 4:0 segregation ERG81erg8 seen bio-                                  URA phenotypes                           URA phenotypes
chemical level, indicating close linkage ERG8                             Spore            spores            Spore            spores
gene integrated plasmid erg8 chromosomal                             phenotype        phenotype          phenotype        phenotype
allele (Table 2). data provided genetic evidence pET45 contained ERG8 gene.                                                    ERG+     URA+                 44        LYS+   URA+               25
   Localization ERG8 gene pET45. localize                        ERG+     URA-                 44        LYS+   URA-               19
                                                                                  ERG-     URA+                  0        LYS-   URA+               19
erg8-1 complementing region pET45, subclones                              ERG-     URA-                  0        LYS-   URA-               25
constructed YCp5O using restriction fragments
shown Fig. 3A. subclones tested                             Plasmid pET46 (ERG8 URA3) integrated erg8 strain ET20-2A
ability complement temperature-sensitive phenotype                         obtain URA + transformant crossed ERG8 strain
                                                                                  JT42-5B. resulting diploids sporulated dissected. Nutritional biochemical defect strain AG8-2A. Data obtained                            markers segregated 2+:2- spored tetrads, ERG8  erg8) plasmids pET51, pET52, pET53, pET74 indicated                            status spores determined biochemical analysis.
 VOL . 1 l, 1991                                                 CLONING S. CEREVISIAE PHOSPHOMEVALONATE KINASE
                                                                                                                                                      625
                                                                854)            .8411               -830          8420            silo
                                                              ACArt; r (  (:'1;ATr              C(X:('C:(;ls' ATAA(;(;AA(;GA AG(,S;AC;ACAT
                         790             -7m0            770) I1ill .711)                           -750              -740            -3
        7120
                                          (;BAArA'1T1' ACCG(C;.AAA ACAA CT CCUCC
                        MT('AAAT'rrl' CA('                                                        AACAIX:C C      (aAA(;AA;TTAIT; AA'AAI(                          710             -70x
       AGAVACGCCA AATAGAIXCTC TATC'&(aCAAAT TA       -690             .680                        670              .66Mb             -6150
                                                            ATA'TAIA ATTC(CCCCCA                  C,C-ACCCTI'CMA GAAACACGAT AAAA((:AAT;
       -640              63(1            -620            4610            *6o0)                      -590            -58(         -570
       TAAt A1V'tI';r TIrCl T't   ACA'TVA GA C mrA'rAl'TA('TA C,CAC(ATG '              C ATAATGAGC(, C^^ACACGATAA CffA(ATAA(:C
                        -5150             540           -W5(
       ATCAAAGTAA ATC.AAC(;(T(AA cGAcCCCC:GAA CAI AA CaCAC' TCCATATA(C'( -520                       -510              -500              .490
                                                                                                    TGVTTAAAGTA GAAGTT'AAAG             AAGAACACGA
       -480             -470             .460           -460
       GGAAATt;C("CT TCAAAAT(IV TACTTGAAGA ACAGAAA(C(CA -440             AGT'ATGGAAC
                                                                                                                -420
                                                                                                    TAATCAATGA TAAAACTAG,T
                                                                                                                                        .410
                                                                                                                                       CCAGAAAATA
       -400             -390)            -380)          -370             -360                       -360        -340                    -330
       ATAATCATCA GGAAACAAAC CCGCAAAAGc ACAAAACTAA                             ACCAAAAAAG           AAAACVC(CTA AAACAAACTA              CAACAG:ACA
       -320        -310         .300        .290                               -280                 -270          .260                 -~250
       AGACCGGAAAA GAAAAATCAC AGAAGGCAGT TCT(CCGCAT                            CAAATACTAA           AAGGCCTACG GGCCACGACC              CAAAAAGCCG
       -240        -230         -220        -210                               -200 Acc1            -190          .18Q                 -~170
       TGACCACGAAT .150
                   ACGATCCAA CTTGTCl=ACI'AA ATAATCAAAT
                          B III -140        -130
                                                                               TGTATACAGC
                                                                               .120
                                                                                                    AATATCTACA TAGTAATAAT              TATrCCGATC
       C160                             11                                                          -110        .100                   -90
        CGrMWITTTA
       .__
                   TACGAGCATT AAAAGUAAAA AAGTI'CGCTT
                _ -7(0          -60         -54)
                                                                               rrAAGGCCGGA
                                                                               -40
                                                                                                    GTTAACGTCA TGTCGAATCG
                                                                                                    -30        -20        -10 CboI
                                                                                                                                       AAACAAACAT
        ITAATXMAATCsGAAAAAC AAAAAAGCCTC AAAAAACAW                              V'CCTGAAGGCC         TCATAATAAA TCAATCGGCT GCCTCGAAA
       1                       15                              30                             45                              60
       ATG TCA GAG TIC AGA GCC rrC ACT CC' CCA CGC AAA CCC TTIA CTA                                 GCT GCT GGA TAT VTA GTT VTA CAT ACA
       Met Ser Clu lou Arg Ala Phe Ser Ala P'ro Cly L.ys Ala Leou Lou                               Ala Cly Cly Tyr Lou Val Lou Asp Thr
       75                   90                   105          SphI
       AAA TAT CAA GCA VIff GTA CTC GA VrA TrCG UCA AGc ATCATT GCT
                                                                                                    120                 135
       Lys Tyr Glu Ala Phe Val Val Cly l.eu Ser Ala Arg Met Ills Ala                                GTA CCC CAT CCT TAC GGT TCA TIC CAA
                                                                                                    Val Ala Pro Tyr            Cly Ser Lou CIn
            150                 165                  180                                                195                            2tO0
        GCC TCT CAT AAC TTT GAA CTG CUT CTG AAA ACT AAA CAA VIT AAA                                 CAT CCC GAG TGG CTG            TAC CAT ATA ACT
       8ly  Ser Asp Lys Phe Glu Val Arg Vail Lys Ser Lys Clii Phe Lys                               Asp Gly Glu Trp Lou            Tyr liis lie Scr
                225                 240                  255                                                270                            285
       CCT AAA ACT CCC TTC ATT CCT CGT TCC ATA CQ( GGA TCT AAG AAC                                  CCT TTC ATT GAA AAA            GTT ATC OCT AAC
       Pro Lys Ser Cly Phe lie Pro Val Ser Ile CIy Gly Ser Lys Asi                                  Pro Ph. lie GU Lys             Val 11. Ala Asn
                    300                 315                                             330            toS A11' GAT A1T TTC                     32A
       GTA TTT AGC TAC Trr AAA CCT AAC( ATG CAC'                       GAC TAC TGC AAT ACA AAC TTC TTCCTT
       Val Phe Ser Tyr Phe Lys Pro Asn Metl Asp                        Asp Tyr Cyi Asn Arg Asn Lou Phe Val 1l1 Asp Ila Ph. 5er
                        375                 390                                               405                             420
       CAT CAT CCC TAC CAT TCT CAC GAC CAT ACC                         CrV ACC GAA CAT CUT          CGC AAC ACA ACA           TTC ACT TITT CAT TCG
       Asp Asp Ala Tyr Hia Ser Cln Glu Asp Ser                         Val Thr Clu liis Arg         Cly Aan Arg Arg           Lou 5cr Phe llia Scr
       435                  450                                        465                          480                         495
       CAC ACA ATT SAA GAA CTT CCC AAA ACA CCC                         CTU CCC TCC TCC GCA          COT TTA CTC ACA        CTT TTA ACT ACA CCT
       Hias Arg lb GIU Gu Val Pro Lys Thr Cly                          Leu Uly Sor Ser Ala          Gly Lou Vail Thr       Vail Lou Thr hMr Ala
                                525                                        540    AGAC AAA                 6M         C57A0'CTAT           V
       TTC WC TCC TTT TTT UTA TCC CAC (TCG CAA                         AAT AAT                      TAT         CAA             CCA
       Lou   AlaSer      Ph.
                        Phe     Ser Asp
                                      Val   Clu          Leu           Aso Asn Val Asp Lys          Tyr Arg Clu       Val Ile Ann Lou Ala
                                                   600                         615                          630                         645
       CAA CTT OCT CAT TUT CAA CCT VAC OCT AAA ATT                         CCA ACC (;(; TTT         CAT CTA CcG        CCC CCA CCA TAT UCA TCT
       Gln Val Ala Cys Gin Ala ln Cly Lys lie                          Cly Ser Cly Phe          Asp Val Ala       Ala Ala Arg Tyr Gly Ser
                   660                  675                                        690                      705                       720
       ATC ACA TAT ACA AGA TTC CCA CCC GCA TTA ATC                         TCT AAT TTC CCA   CAT ATT GCA ACT CUT ACT TAC CCC ACT
       1le Arg Tyr Arg Arg Ph. Pro Pro Ala Leu 11                          5cr Aan Lou Pro   Asp IIs Cly Ser Ala Thr Tyr Cly Ser
                       735                  750                                         766                       780
       AAA CTC CCC CAT TT CGTT CAT CAA GAA CAC TCG                         AAT ATT ACC ATT   AAA ACT AAC CAT VTA CCT T(CU GGA TTA
       Lys Lou Ala Lou Val Asp GCU GCU Asp Trp                         Aso Ile Thr i0    Lya Ser Asn Ills Lou Pro 5cr CIy Lou
       795                  810                 825                                          840                       855
       ACT TVA TUG ATG CCCG CAT ATT AAC AAT sGT TCA                     CAA ACA CTA AAA CTG CTC CAC AAC GTA AAA AAT TUG TAT
       Thr Lou Trp Met Cly Asp II   Lys Aan Cly Sor                     Glu Thr Val Lys Leu Val Cin Lys Val Lys Aan Trp Tyr
             870
       CAT TCG CAT ATU CCA CAA ACC TTC
                                             885                        900                       9IS         T.hal.
                                                         AAA ATA TAT ACA CAGA CTC CAT CAT GCA AAT TUT AGA TT ATU CAT GGA
                                                                                                                            930
       Asp Ser Met Pro Clu Ser Leu                   lyas lie Tyr Thr Clu Lou Asp Ala Asn Ser Arg Ph. Met Asp Cly
               945                 960                                         975                     990                       1005
       CTA TCT AAA CTA CAT CGC TTA CAC                   GAG ACr CAT CAC CAT TAC ACC CAT CAC ATA TVT GAC TCT CTT SAC AUG
       Lou Ser Lys Lou Asp Arg Lou                   Ulu Thr Asp Asp Tyr Ser Asp Cln Ile Ph. Clu Ser Lou lu Arg
                   1020 TOT AA AAG TAT
       AAT GAC TGT Thr
                   ACC
                                                         1035
                                                         CCIT CAA ATC ACA CAA COTT 1050 ACA CAT CCA CTT G('c106
                                                                                                                  ACA ATT AGA CUT 1rC
                                                                                                                                                                                                                                                                         1080
       Amn Asp Cys      Cys ln Lys Tyr                   Pro Glu lie Thr Clu Val Arg Asp Ala Val Ala Thr lie Arg Arg aer
                               1095                            1110 ECORV               1125                      1140
      TTT ACA AAA ATA ACT AAA                 "AA TCT    GCT CCC CAT ATC CAA CCr CCC CTA CAA ACT sC TTA TTC C CAT TC'
      Ph. Arg l.ys IIe Thr l1ys              Glu 8r      Gly Ala sp iie Clu Pro Pro Val Cin Thr Ser lou lou Asp Asp Cys
      IlI                   1170                                   1185                      1200                      1215
      CAG AC-C' TTA AAA GGA CTT              CTT 'ACT    TGC( TTA ATA C'C'T CCT GC'T CCT QGT TAT GAC' ;CCC ATT (XIA GTG AVI' 'T
      Gln Thr Lou Lysa Cly Val               Leu Thri    Cys Lou lIe 1ro Clgy Al Clgy ly Tyr Asp AJla                Ala Val lie Thr
             1230                       1245                            1260                      1275                 1285           1295
       AAC   C`AA CAT   ( T (CAT CVIT ACC
       Lys GIn Asp Val Asip Lou Arg Ala
                                             CGIC        CAA CCC (TA ATG ACA AAA CAT TTC TAA
                                                         Uin Pro LAu Met Thr l.ys Phe c
                                                                                                             C(C`TTA(AATGC  (CITCA1TCTAA.
                 130X(          131(3                    1:320          1:130i          1340           1360            1360           1370
       T XX,TAC T; G;TTA GGAAAGAAAA AGA'CC(;GAA CTA1XTM' ATAAATAAC'T TAACGTACAT AATAC;T:Tt'
                 1310           1390            14(W)         1410           1420(       1430          144()         14501
       C ;T(;GA C"ITTATAAAT (IA AGM(;7'rCs ACAA(Wr (;(CTGCAACATC TAA(  TCVI''CCATA CTA AAA
                 1460           1470)           14W0          1490          150        1510          1524)         1530
        'WVII:X"VIl(- OC(XXCAT(:'e' AAAAVI'('T rTfTAATIX;GCT AC(AAC'CTrrTA C(ATA(CTACA TI;(ACCATAICsT IIA'OAAAC(
                 1540 Xhal      &411
      ATIAAATAAAC(: VrTll   FIG. 4. Nucleotide predicted amino acid sequence ERG8 gene. Nucleotides DNA sequence numbered starting ERG8 translational start site nucleotides 5'-untranslated region designated negative numbers. predicted amino acid
sequence phosphomevalonate kinase shown underneath. consensus TATA box enclosed box, possible polyadenylation
signals near 3' end underlined. Restriction sites labeled underlined overlined.
 626     TSAY ROBINSON                                                                                                     MOL. CELL. BIOL.

Concensus                       - - -   -G   G        G     X(12-25)..     K      (9). codon bias index 0.31 calculated                                                                                   predicted ERG8 protein, suggesting low moderate expres-
ERG8           ISOV                                                               sion gene S. cerevisiae.
                      P -     K T G L G S         S G      ...X(25)...   K183
                                                                                     Disruption ERG8 gene chromosomal locus. HSKI           90M    P     G S       G L G S   S   C    ...X(16)...   K116   determine ERG8 gene essential isoprene
                                                                                  sterol biosynthesis S. cerevisiae, chromosomal dis-
RAR1           140L   P     G G L G S S S              ...X(24)... K174     ruptions gene constructed method GALl           162    P   T G           G L SS S S            X(2)... K19S
                                                                                  Rothstein (44). large internal region ERG8 coding
                                                                                  region replaced DNA fragments containing select-
                                                            ...




  FIG. 5. Peptide homologies phosphomevalonate kinase                     able markers (Fig. 6A). Constructs contained ERG8 proteins. consensus sequence ATP-binding site                gene disrupted URA3 gene HIS3 gene
present protein kinases aligned deduced amino                 transformed linear DNA fragments diploid
acid sequence yeast phosphomevalonate kinase (ERG8), E. coli                   strain ET16, heterozygous erg8 mutation
homoserine kinase (HSKI), yeast RARI protein, yeast galac-                    (Table 1). Stable uracil histidine prototrophs se-
tokinase (GAL]). Positions homologous peptides respective proteins indicated superscript numbers.                         lected; approximately half type                                                                                   temperature sensitive growth 37°C, suggesting                                                                                   contained disruption ERG8 allele                                                                                   chromosome. confirm temperature-sensitive
sensus sequence element (31) region,                        URA+  diploid cells contained appropriate null
indicating ERG8 mRNA spliced. incom-                           alleles ERG8 gene, Southern analysis 
plete ORF 637 bp (Fig. 3A; Fig. 4, positions -846                           formed. Genomic DNA disrupted undis-
-200) begins 5' BglII site terminates near                     rupted strains examined (Fig. 6B). DNA AccI site detected 207 bp upstream ERG8                           undisrupted strains yielded single 3.6-kb band, demonstrat-
ORF. function incomplete ORF                         ing erg8-1 ERG8 alleles present diploid
study.                                                                            strain similar size. Chromosomal DNA    Searches EMBL/GenBank PIR data bases                           ERG8-disrupted diploid strains produced second band ERG8 DNA predicted protein sequence failed                              4.6 4.8 kb. additional bands size
identify closely related genes proteins.  lim-                       ERG8:: URA3 ERG8::HIS3 disruption fragments
ited region ERG8 protein beginning amino acid 150                       plasmids pET61 pET62 (Fig. 6B, lanes 7 8), share homologous sequences                              proving represented new alleles, erg8-AJ proteins (Fig. 5). indicated, proteins                         erg8-A2, ERG8 gene.
contain motif Gly-X-Gly-XX-Ala-X(13-26)-Lys. simi-                             examine phenotype ERG8 disrupted cells, tem-
lar motif contains glycine instead alanine                    perature-sensitive URA+  prototrophs strain
residue described (23, 36). Considerable                       ET16 sporulated dissected. 10 complete tet-
evidence suggests structure forms ATP-binding                        rads ERG8:: URA3 diploid 22 complete tetrads
pocket kinases (23, 36). Phosphomevalonate kinase                         ERG8::HIS3 diploid, spore viability segregated 2 proteins identified Fig. 5 use modified                          live:2 dead YCE (Table 3). viable spores tetrads
version structure serve comparable function.                         ura  respectively, diploids,
Searches data bases incomplete 5'-ORF DNA                         indicating inviable spores contained deletion predicted protein sequence turned homologous                             markers. results obtained tetrads
sequences.                                                                        derived ERG8 homozygous diploid strain YM197
  yeast genes contain TATA box-related sequences                             ERG8 alleles disrupted HIS3
upstream coding regions serve basal promoter                     marker (Table 3).  results confirmed data
elements. typically 60 120 bp upstream                       Southern blot analysis showed ERG8 transcription initiation sites (22). strong match                    single-copy essential gene haploid yeast cells.
consensus yeast TATA sequence present position -80                             Transformation strain ET16 ERG8::HIS3 dis-
(TATATAAA) ERG8 nucleotide sequence (Fig. 4).                              ruption gave rise equal numbers temperature-sensitive
Weak matches consensus sequence                         non-temperature-sensitive diploids, suggesting positions -120 (TCTAAA) -198 (TATACA). signif-                             equal likelihood disrupting ERG8
icant inverted repeat sequences  8-bp perfect                      erg8-1 allele strain. examine premise, repeat sequences  positions -447 -455 -483                         temperature-sensitive non-temperature-sensitive -491) 20-bp imperfect repeat sequences                             ERG8::HIS3 diploid transformed multicopy
positions -556 -585 -644 -663)                           plasmid pET58, contained ERG8 URA3
detected upstream presumptive ERG8 TATA boxes.                             genes, tetrad dissection. Spore viability significance sequences transcription                       URA+ marker segregated 4+:0- tetrads derived ERG8 gene remains tested.                                               diploids (Table 3). Furthermore, URA+
   Sequences required efficient termination transcrip-                      spores temperature sensitive. results demon-
tion RNA polyadenylation described                             strated ERG8 gene rescued inviability number yeast genes. tripartite termination elements                       erg8-A2 disruption complemented erg8-1 mutation. type proposed Zaret Sherman (58)                         verify findings, isolated spores tetrads 3' end ERG8 gene.  sequences similar                         streaked YME plates contained 5-flu- putative consensus polyadenylation signal,                            oroorotic acid counterselect cells carried URA+
AATAAA, detected 72 113 bp downstream                              plasmid (11). tetrads examined, ERG8 TAA stop codon (Fig. 4). frequency codon use                           spores tetrad viable 5-fluorootic ERG8 coding region showed striking bias                           acid plates. viable spores consistently codons utilized highly expressed yeast genes                         temperature sensitive  depending  VOL. 11, 1991                                                            CLONING S. CEREVISIAE PHOSPHOMEVALONATE KINASE                                                      627

                               
                                                   R       P            Bg             BgXS               SsHXb E            Xb    R
                                                                                        IiI.1.         i_                                                ERG 8                                                                                                       3.6 Kb


                                                                                                                        URA3

                                     erg 8-1 F-                                                                                                    4.6 Kb
                                                                                                            HIS3
                                                                                                                                 -14
                                     erg 8-A2 -                                                                                                    4.8 Kb
                                                                                             x                                                B
                                     probe                                                                                                   - 
                                B.                              Kb 1 2 3 4 5 6 7 8   Kb
                                                                 5-                _48Kb
                                                                     4-
                                                                                                                  4.6Kb
                                                                                             _~4.
                                                                  4-

                                                                                                             -    3.6Kb
                                                                3-



                                                                 2-

                                                               1.6-'
  FIG. 6. Southern blot analysis yeast genomic DNA.   Diagrammatic representation ERG8 fragments pBR322-based
plasmids pET61 (ERG8:: URA3) pET62 (ERG8::HIS3) used create ERG8 chromosomal disruptions, erg8-AI] erg8-A2. restriction map symbols described legend Fig. 3B. Fragment sizes listed right indicate ERG8 band sizes
expected EcoRI digestion plasmid genomic DNA containing disruptions. (B) Southern analysis EcoRI-digested yeast genomic
DNA (lanes 1 5) plasmid DNA (lanes 6 8). Genomic DNA ERG8 haploids (lanes 1 2), ERG81erg8-1 diploid
ET16 (lane 3), erg8 1erg8-1 diploid (lane 4), erg8-A2/erg8-1 diploid (lane 5), plasmid DNA pET45, pET61, pET62 (lanes 6 8, respectively). lanes probed radiolabeled XhoI-BamHI ERG8 fragment shown Fig. 6B.


came       temperature-sensitive               non-temperature-sen-                       experiments indicated alternate ERG8 alleles sitive diploid originally.  erg8-A2 allele rescue                                     disrupted heterozygous diploid strain.
erg8-1 allele complementation dependent                                                 Expression ERG8 gene GALl promoter. continuous presence ERG8 plasmid. results                                            described  levels phosphomevalonate kinase were obtained analysis low-                                              increased severalfold wild-type cells bearing ERG8
copy-number ERG8 plasmid pET63 (Table 3).                                                  gene multicopy plasmid.  level expres-



                                                    TABLE 3. Genetic analysis ERG8 gene disruptions
          Diploid strain                                                     Spore viability                                                         Spore segregationa
   Disruption'             Plasmid'          4 :O               3+:1°            2+:2°              1+:3°           0+:4°         ERG8:erg8                 URA3:ura3     HIS3:his3
YM197
  ERG8:: URA3                             0                 0                 13                 0                  0             2:0                     0:2          NA
ET16
  ERG8::URA3                              0                 0                 10                 0                  0             0:2                    0:2           NA
  ERG8::HIS3                              0                 0                 22                 0                  0             0:2                    NA            0:2
  ERG8::HIS3               pET58               7                 0                  0                 0                  0             4:0                    4:0           2:2
  ERG8::HIS3               pET63               5                 0                  0                 0                  0             4:0                    4:0           2:2
  erg8::HIS3                              0                 0                 19                 0                  0             2:0                    NA            0:2
  erg8::HIS3               pET58              13                 0                  0                 0                  0             4:0                    4:0           2:2
  aERG8  erg8) status spores determined biochemical analysis. NA, applicable.
  bThe wild-type diploid strain YM197 (ERG8/ERG8) heterozygous diploid strain ET16 (ERG81erg8) disrupted ERG8  erg8) allele integration linear ERG8:: URA3 ERG8: :HIS3 disruption fragment.
  c ERG8: :HIS3 diploids secondarily transformed pET63 (YCp5O) pET58 (YEp352) plasmids contained URA3 ERG8
structural genes sporulation tetrad dissection.
 628     TSAY ROBINSON                                                                                                        MOL. CELL. BIOL.


                                                                               B.      pMH101      pET 77
                                                                                         GLU GAL GLU GAL M            MW



                                                                                                                   -200




                                                                                                .                  -97

                                                                                                                "u-68

                                                                                                                    -13



                                                                                                _               _~~-26

                                                                                                                    -18
                                                                                           1    2    3     4
  FIG. 7. Overexpression ERG8 gene GAL] promoter.   Structure multicopy plasmid pET77 used galactose
inducible expression ERG8 gene S. cerevisiae. details plasmid construction Materials Methods. (B) Yeast cells contained pET77 parent plasmid pMH101 grown overnight glucose medium (GLU) galactose medium (GAL). Equal amounts cell protein electrophoresed 12  sodium dodecyl sulfate-polyacrylamide gel stained Coomassie blue. arrow
indicates position overexpressed 48-kDa ERG8 protein lane 4. M, Molecular size markers.


sion low permit ERG8 gene product                  findings utilized erg8-1 mutant isolate yeast
identified sodium dodecyl sulfate-polyacrylamide gels                library plasmid complemented temperature-
(data shown). obtain higher levels expression,            sensitive biochemical defects mutant strain. ERG8 coding region placed regulatory control              plasmid shown genetic analysis contain yeast yeast galactokinase (GALl) promoter plasmid                   ERG8 gene. Southern analysis, gene disruption, plasmid
pET77 (Fig. 7A). parent vector pMH101 (21) pET77                rescue experiments confirmed cloned gene  transformed GAL' strain, strain                 tained sequences corresponded ERG8 chromo-
grown YM-glucose transferred YM-galactose                somal locus. Consistent known gene dosage effects, induce expression GAL] promoter. Protein                    ERG8 gene present cells high-copy-
extracts glucose- galactose-grown cells run               number plasmid, corresponding eightfold overproduction sodium dodecyl sulfate-polyacrylamide gels (Fig. 7B).                phosphomevalonate kinase observed.
Extracts pET77-transformed cells grown                   Subcloning nucleotide sequence analyses showed galactose contained strong band approximately 48 kDa.              yeast ERG8 gene encoded unexpectedly large protein analogous band seen extracts pET77-                  approximately 47 kDa. Previous characterizations transformed cells grown glucose cells              porcine phosphomevalonate kinase shown 22
bearing pMH101 grown carbon source. size                  kDa (6, 32). difference protein size surprising, galactose-regulated expression protein strongly             date comparisons yeast mammalian
implied predicted (47.3-kDa) ERG8 gene                  clones enzymes sterol biosynthesis, including
product. confirm  extracts analyzed                   HMG CoA synthase (27a), HMG CoA reductase (5), meval-
standard spectrophotometric assay phosphomevalonate                 onate kinase (51a), farnesyl diphosphate synthetase (3), kinase activity. Extracts pET77-transformed cells                  lanosterol demethylase (28), revealed strong conserva-
grown galactose nearly 1,000 times enzyme
activity did extracts cells grown glucose (Table
4). Simple chromatographic fractionation extracts                  TABLE 4. Phosphomevalonate kinase activity ergosterol
taining overexpressed protein demonstrated phos-                                content yeast strainsa
phomevalonate kinase activity copurified 48-kDa
protein (data shown). excess ergosterol accumulated,             Strain        Plasmid        Medium           Ergosterol        Sp act (nmol/
                                                                                                                     content ()            min/mg) deleterious effects enzyme overexpression observed, prolonged growth (72 h) cells                Y294          pMH101        Glucose               0.76                <15
YM-galactose.                                                           Y294          pMH101        Galactose             0.80                <15
                                                                        Y294          pET77         Glucose               0.75                <15
                                                                        Y294          pET77         Galactose             0.82             13,200
                            DISCUSSION                                                                                                                 Yeast cells contained pMH101  ERG8) pET77    Studies Karst Lacroute suggested yeast strains            ERG8) grown overnight minimal medium indicated carbon contained erg8 mutations blocked isoprene              source. Phosphomevalonate kinase activity crude ergosterol content                                                                         cells (percentage dry cell weight) determined described Materials
ergosterol biosynthesis presence thermolabile           Methods. specific activity 15 corresponds minimal phosphomevalonate kinase (29). investigation confirmed              enzyme detectable spectrophotometric assay used.
 VOL . 1 l, 1991                                      CLONING S. CEREVISIAE PHOSPHOMEVALONATE KINASE                             629

tion protein size protein sequence. Molecular         formed inviable colonies medium contained ergoste-
cloning cDNA encoding mammalian phosphomeval-             rol, tetrad dissection anaerobic
onate kinase necessary determine regions       conditions known enhance ergosterol uptake S. cere- yeast polypeptide conserved smaller           visiae (4). Repeated attempts rescue inviability erg8
mammalian protein. Potentially, additional sequences           null mutants addition dolichol ubiquinone present yeast phosphomevalonate kinase confer           medium ergosterol unsuccessful. novel properties associated mammalian           findings suggest requirement additional isoprene-
enzyme. possibility explored future            derived products farnesol support growth erg8
characterization yeast enzyme.                              null mutants. contrast erg8 results, null mutants
   feature phosphomevalonate kinase deduced             lanosterol demethylase (28) squalene monooxygenase ERG8 nucleotide sequence location            (52a) viable grown medium supplemented
small peptide represent portion enzyme           ergosterol.  enzymes utilized
active site. importance suggested finding         exclusively ergosterol biosynthesis. prove homologous peptides present similar positions         interesting examine effect erg8 mutations known potential (RARI) metabolic ki-           processes rely isoprene-derived products, nases. support idea came recogni-        protein farnesylation.
tion related peptide motif identified protein      curious finding study phosphomeval-
kinases (23). tyrosine serine threonine protein          onate kinase accumulate S. cerevisiae high
kinases lysine residue consensus motif, GXiX            levels toxicity. Densitometric scanning protein
X... .K, thought serve contact point,           gels indicated phosphomevalonate kinase constituted
glycine repeat thought serve pocket ATP             approximately 20 o soluble protein growth cells binding (23, 36). Phosphomevalonate kinase proteins        galactose medium. Despite enormous elevation 
shown Fig. 5 contain GAGL-iSSA... K motif          zyme levels, cells appeared normal visible unlikely possess protein kinase activity lack      phase-contrast microscopy. Likewise, viability additional peptide motifs conserved protein    cell doubling time appreciably altered cells.
kinases.  motif ERG8 protein              ergosterol accumulation cells involved ATP binding, alanine substitutions       greater control cultures, indicating glycine residue described nucleo-         overexpression phosphomevalonate kinase little ef-
tide binding proteins (36). Modification motif           fect synthesis isoprene-derived product. Sim-
phosphomevalonate kinase mutagenesis permit              ilar findings previously reported studies significance motif determined.                   activity acetoacetyl CoA thiolase (16) HMG CoA
   ERG8 promoter analysis conducted,           reductase (56) increased tenfold yeast strains bearing truncation ERG8 upstream se-              corresponding structural gene multicopy plasmid.
quences position -140 rendered gene unable               studies  yeast sterol
complement erg8 mutant. result indicate          production regulated primarily rate-
sequences upstream ERG8 consensus TATA              limiting enzymes sterol biosynthesis HMG CoA
box required optimal expression gene.             synthetase squalene synthetase. Alternatively, vivo
puzzling finding complete ERG8 coding region          mechanisms exist regulating enzyme
carried pET63, absence upstream sequences,            activity increases measured vitro assays. complement erg8 defect. likely        begun testing various sterol isoprenoid compounds reflected joining ERG8 coding region spurious      act feedback inhibitors phos-
promoter vector sequences. precedent vector          phomevalonate kinase manner consistent vivo
artifacts established studies (8).        regulation enzyme.
currently examining cis-acting elements ERG8
promoter greater                                                               ACKNOWLEDGMENTS
   Karst Lacroute (29) postulated exogenous ergo-            thank Wolfram Siede YCp5O genomic library. sterol improved growth erg8-1 mutants            appreciate critical reading manuscript Tobe Fisch,
allowed divert limited isoprene supply      Jessica Gorman, Richard Gregg, William Scott. grateful
synthesis essential products ergosterol.      colleagues Jan Tkacz, Richard Tanaka, Don Kirsch, Myra
course cloning work, compared growth              Kurtz, Rose Kelly helpful discussions. thank Ellen
ergosterol medium erg8 mutants           Tornquist Jose Alcantara contributions prepara-
erg8 upcl mutants healthier parent erg8              tion manuscript illustrations, respectively.
                                                                      acknowledge Bristol-Myers Squibb Pharmaceutical Research
strains, judged number criteria. Unlike erg8            Institute supporting basic aspects research sterol metabo-
strains, erg8 upcl strains formed uniformly sized         lism.
colonies permissive temperatures. believe differences reflect consistent uptake ergosterol erg8 upcl cells. upcl mutation reported                               ADDENDUM
similar effects growth yeast mutants defective              ERG8 protein sequence reported contains oxidosqualene cyclase (34), enzyme ergosterol           polypeptide domains highly conserved
biosynthesis. observations growth erg8 upcl          rat mevalonate kinase (52) yeast meval-
mutant cells consistent Karst Lac-          onate kinase, recently cloned laboratory (42a).
route hypothesis.                                                                         REFERENCES
   presence ergosterol, growth erg8 erg8       1. Anderegg, R. J., R. Betz, S.  Carr, J. W. Crabb, W.
upcl cells blocked restrictive temperatures, indicating          Duntze. 1988. Structure Saccharomyces cerevisiae mating phosphomevalonate kinase essential               hormone factor: identification S-farnesyl cysteine just ergosterol synthesis. Haploid erg8 null strains likewise          structural component. J. Biol. Chem. 263:18236-18240.
 630     TSAY ROBINSON                                                                                                  MOL. CELL. BIOL.

 2. Anderson, M. S., M. Muehibacher,  P. Street, J. Proffitt,           ase Saccharomyces cerevisiae detection virus-specific
    C. D. Poulter. 1989. Isopentenyl diphosphate: dimethylallyl               enzyme activity cell-free lysates. J. Virol. 62:4493-4498.
    diphosphate isomerase; improved purification enzyme         22. Hahn, S., E. T. Hoar, L. Guarente. 1985.     isolation gene Saccharomyces cerevisiae. J.               "TATA elements" specifies subset transcription initi-
    Biol. Chem. 264:19169-19175.                                              ation sites CYCI promoter Saccharomyces cerevisiae.
 3. Anderson, M. S., J. G. Yarger, C. L. Burck, C. D. Poulter.            Proc. Natl. Acad. Sci. USA 82:8562-8566.
    1989. Farnesyl diphosphate synthetase: molecular cloning, se-         23. Hanks, S. K.,  M. Quinn, T. Hunter. 1988. protein
    quence expression essential gene S. cerevisiae.            kinase family: conserved features deduced phylogeny     J. Biol. Chem. 264:19176-19184.                                           catalytic domains. Science 241:42-52.
 4. Andreasen,  , T. J. B. Stier. 1953. Anaerobic nutrition       24. Heilig, H., G. Popjak. 1961. Studies biosynthesis     Saccharomyces cerevisiae.  Ergosterol requirement                cholesterol. XIII. Phosphomevalonic kinase liver. J. Lipid
    growth defined medium. J. Cell. Comp. Physiol. 41:23-35.             Res. 2:235-243.
 5. Basson, M. E., M. Thorsness, J. Finer-Moore, R. M. Stroud,        25. Hinnen, , J. B. Hicks, G. R. Fink. 1978. Transformation     J. Rine. 1988. Structural functional conservation             yeast. Proc. Natl. Acad. Sci. USA 75:1929-1933.
    yeast human HMG-coenzyme reductases, rate-                  26. Holmes, D. S., M. Quigley. 1981. rapid boiling method     limiting enzyme sterol biosynthesis. Mol. Cell. Biol. 8:3797-          preparation bacterial plasmids. Anal. Biochem. 114:193-
    3808.                                                                     197.
 6. Bazaes, S., E. Beytia,  M. Jabalquinto, F. S. Ovando,          27. Ishibashi, Y., Y. Sakagemi,  Isogai,  Suzuki. 1984.
    Gomez, J. Eyzaguirre. 1980. Pig liver phosphomevalonate               Structures tremerogens 9291 9291-VIII: petidyl sex
    kinase.  Purification properties. Biochemistry 19:2300-             hormones Tremella brasiliensis. Biochemistry 23:1399-1404.
    2304.                                                                 27a.Jarman, K., T. Mozer. Personal communication.
 7. Bazaes, S., E. Beytia,  M. Jabalquinto, F. S. Ovando,          28. Kalb, V. F., C. W. Woods, C. R. Dey, T. R. Sutter, T. G. Turi,
    Gomez, J. Eyzaguirre. 1980. Pig liver phosphomevalonate               J. C. Loper. 1987. Primary structure P450 lanosterol
    kinase. II. Participation cysteinyl lysyl groups cataly-        demethylase gene Saccharomyces cerevisiae. DNA 6:529-
    sis. Biochemistry 19:2305-2310.                                           537.
 8. Beier, D. R.,  Sledziewski, E. T. Young. 1985. Deletion         29. Karst, F., F. Lacroute. 1977. Ergosterol biosynthesis     analysis identifies region, upstream ADH2 gene                Saccharomyces cerevisiae. Mol. Gen. Genet. 154:269-277.
    Saccharomyces cerevisiae, required ADRJ-medi-            30. Laemmli, U. K. 1970. Cleavage structural proteins     ated derepression. Mol. Cell. Biol. 5:1743-1749.                          assembly head bacteriophage T4. Nature (London)
 9. Bennetzen, J. L., B. D. Hall. 1982. Codon selection yeast.         227:680-685.
    J. Biol. Chem. 257:3026-3031.                                         31. Langford, C. J., F. J. Klinz, C. Donath, D. Gallwitz. 1984.
10. Bloch, K., S. Chaykin,  H. Phillips,  Waard. 1959.             Point mutations identify conserved, intron-contained
    Mevalonic acid pyrophosphate isopentenylpyrophosphate.                TAACTAAC box essential splicing signal sequence     J. Biol. Chem. 234:2595-2604.                                             yeast. Cell 36:645-653.
11. Boeke, J. D., F. Lacroute, G. R. Fink. 1984. positive           32. Lee, C. S., W. J. O'Sullivan. 1985. Improved procedures     selection mutants lacking orotidine-5'-phosphate decarbox-            synthesis phosphomevalonate assay     ylase activity yeast: 5-fluoro-orotic acid resistance. Mol. Gen.       purification pig liver phosphomevalonate kinase. Biochim.
    Genet. 197:345-346.                                                       Biophys. Acta 839:83-89.
12. Boll, M., M. Lowel, J.  J. Berndt. 1975. Sterol biosyn-     33. Levy, H. R., G. Popjak. 1960. Studies biosynthesis     thesis yeast. 3-Hydroxy-3-methylglutaryl CoA reductase            cholesterol X. Mevalonic kinase phosphomevalonic kinase
    regulatory enzyme. Eur. J. Biochem. 54:435 444.                           liver. Biochem. J. 75:417-428.
13. Botstein, D., S. C. Falco, S. E. Stewart, M. Brennan, S. Scherer,     34. Lewis, T. , F. R. Taylor, L. W. Parks. 1985. Involvement
    D. T. Stinchcomb, K. Struhl, R. W. Davis. 1979. Sterile host          heme biosynthesis control sterol uptake S. cerevi-
    yeasts (SHY): eukaryotic biological containment recombi-            siae. J. Bacteriol. 163:199-207.
    nant DNA experiments. Gene 8:17-24.                                   35. Miller, J. H. 1972. Experiments molecular genetics, p.
14. Bradford, M. M. 1976. rapid sensitive method                431-435. Cold Spring Harbor Laboratory, Cold Spring Harbor,
    quantitation microgram quantities protein utilizing             N.Y.
    principle protein-dye binding. Anal. Biochem. 72:248-254.          36. Moller, W., R. Amons. 1985. Phosphate-binding sequences
15. Brown, M., J. Goldstein. 1980. Multivalent feedback regu-             nucleotide-binding proteins. FEBS Lett. 186:1-7.
    lation HMG CoA reductase, control mechanism coordinat-           37. Mortimer, R. K., D. C. Hawthorne. 1969. Yeast genetics, p.
    ing isoprenoid synthesis cell growth. J. Lipid Res. 21:505-           385-460.  H. Rose J. S. Harrison (ed.), yeasts, vol.
    517.                                                                      1. Academic Press, , New York.
16. Dequin, S., F. Boutelet, M. Servouse F. Karst. 1988. Effect       38. Nasmyth, K. , K. Tatchell. 1980. structure trans-
    acetoacetyl CoA thiolase amplification sterol synthesis          posable yeast mating type loci. Cell 19:753-764.
    yeasts S. cerevisiae S. uvarum. Biotechnol. Lett.             39. Naumovski, L., E. C. Friedberg. 1982. Molecular cloning      10:457-462.                                                              eucaryotic genes required excision repair UV-irradiated
17. DiHanich, M. E., D. Najarian, R. Clark, E. C. Gillman, N. C.              DNA: isolation partial characterization RAD3 gene     Martin,  Hopper. 1987. Isolation characterization            Saccharomyces cerevisiae. J. Bacteriol. 152:323-331.
    MOD5, gene required isopentenylation cytoplasmic         40. Naumovski, L., E. C. Friedberg. 1984. Saccharomyces
    mitochondrial tRNAs Saccharomyces cerevisiae. Mol. Cell.               cerevisiae RAD2 gene: isolation, subcloning, characteriza-
    Biol. 7:177-184.                                                          tion. Mol. Cell. Biol. 4:290-295.
18. Faust, J. R., J. L. Goldstein, M. S. Brown. 1979. Synthesis       41. Okayama, H., P. Berg. 1982. High efficiency cloning     ubiquinone cholesterol human fibroblasts: regulation            length cDNA. Mol. Cell. Biol. 2:161-170.
    branched pathway. Arch. Biochem. Biophys. 192:86-99.             42. Popjak, G. 1969. Enzymes sterol biosynthesis